Robot-Assisted Therapy (RAT) has successfully been used to improve social skills in children with autism spectrum disorders (ASD) through remote control of the robot in so-called Wizard of Oz (WoZ) paradigms.However, there is a need to increase the autonomy of the robot both to lighten the burden on human therapists (who have to remain in control and, importantly, supervise the robot) and to provide a consistent therapeutic experience. This paper seeks to provide insight into increasing the autonomy level of social robots in therapy to move beyond WoZ. With the final aim of improved human-human social interaction for the children, this multidisciplinary research seeks to facilitate the use of social robots as tools in clinical situations by addressing the challenge of increasing robot autonomy.We introduce the clinical framework in which the developments are tested, alongside initial data obtained from patients in a first phase of the project using a WoZ set-up mimicking the targeted supervised-autonomy behaviour. We further describe the implemented system architecture capable of providing the robot with supervised autonomy.

Robot-assisted therapy (RAT) offers potential advantages for improving the social skills of children with autism spectrum disorders (ASDs). This article provides an overview of the developed technology and clinical results of the EC-FP7-funded Development of Robot-Enhanced therapy for children with AutisM spectrum disorders (DREAM) project, which aims to develop the next level of RAT in both clinical and technological perspectives, commonly referred to as robot-enhanced therapy (RET). Within this project, a supervised autonomous robotic system is collaboratively developed by an interdisciplinary consortium including psychotherapists, cognitive scientists, roboticists, computer scientists, and ethicists, which allows robot control to exceed classical remote control methods, e.g., Wizard of Oz (WoZ), while ensuring safe and ethical robot behavior. Rigorous clinical studies are conducted to validate the efficacy of RET. Current results indicate that RET can obtain an equivalent performance compared to that of human standard therapy for children with ASDs. We also discuss the next steps of developing RET robotic systems.

Children with autism spectrum disorders (ASD) have persistent deficits in social communication and social interaction, as well as restricted, repetitive patterns of behavior, interests, or activities [1]. The prevalence of autism is estimated at 1-2 per 1000, and close to 6 per 1000 for ASD [23]. ASD is a lifelong disorder, and many individuals need high levels of support throughout their lives [28]. Even though no cure has been found, early intervention is critical for a positive long-term outcome. The interventions that have received the most empirical support are early behavioral interventions. They usually involve one-on-one training provided by a therapist, in which children are trained to respond to environmental changes, understand and use language, and interact appropriately with others in social settings [8].

We present a dataset of behavioral data recorded from 61 children diagnosed with Autism Spectrum Disorder (ASD). The data was collected during a large-scale evaluation of Robot Enhanced Therapy (RET). The dataset covers over 3000 therapy sessions and more than 300 hours of therapy. Half of the children interacted with the social robot NAO supervised by a therapist. The other half, constituting a control group, interacted directly with a therapist. Both groups followed the Applied Behavior Analysis (ABA) protocol. Each session was recorded with three RGB cameras and two RGBD (Kinect) cameras, providing detailed information of children’s behavior during therapy. This public release of the dataset comprises body motion, head position and orientation, and eye gaze variables, all specified as 3D data in a joint frame of reference. In addition, metadata including participant age, gender, and autism diagnosis (ADOS) variables are included. We release this data with the hope of supporting further data-driven studies towards improved therapy methods as well as a better understanding of ASD in general.